ArticleHaematologica2021

Dose-adjusted EPOCH-rituximab or intensified B-NHL therapy for pediatric primary mediastinal large B-cell lymphoma.

Fabian Knörr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.